In silico study of Sambiloto (Andrographis paniculata) compounds from GC-MS and LC-MS/MS as alpha-glucosidase and DPP-4 enzyme inhibitor

Authors

  • Herni Kusriani Bhakti Kencana University
  • Purwaniati Purwaniati Bhakti Kencana University
  • Muhamad Ilham Bintang Bhakti Kencana University

DOI:

https://doi.org/10.12928/pharmaciana.v14i3.26643

Keywords:

alfa-glucosidase, diabetes mellitus, DPP-4, molecular docking, sambiloto (Andrographis paniculate)

Abstract

Diabetes mellitus is a group of metabolic diseases characterized by hyperglycemia, impaired insulin secretion, and insulin action. To overcome this disease, some people treat it with natural ingredients. Sambiloto (Andrographis paniculata) is reported to have a wide range of pharmacological activities, one of which is anti-diabetic. Sambiloto showed activity in lowering blood glucose which has the potential as an antidiabetic. Computational methods, such as molecular docking, can increase the effectiveness and reduce the cost of searching for new active compounds. The purpose of this study was to determine the component compounds contained in the ethanol extract of Sambiloto and obtain the potential compounds to inhibit the alpha-glucosidase and DPP-4 enzymes as anti-diabetics with molecular docking method. Sambiloto leaves were macerated for 3 x 24 hours using ethanol 96% as a solvent and concentrated with an evaporator. Sambiloto extract was analyzed using LC-MS, and GC-MS. In-silico analysis includes geometry optimization and molecular docking methods. Preparation of the test ligands was carried out by the ChemBioDraw Ultra and ChemBio3D applications, then optimization by Gaussian 09 application. The crystal structures of the target proteins used were those with PDB ID 5NN8 for alpha-glucosidase and 2QOE for DPP-4. Molecular docking was performed using Autodock 4.2.3 application. From analysis with LC- MS/MS and GC-MS methods, 18 compounds were identified. Molecular docking was performed on the identified compounds. The results of molecular docking showed that the compound S17 (11-(P- Bromoanilino)-5H-Dibenzo [B,E] [1,4] Diazepine), S1 (andrographolide) and S2 (andrographanin) have the potential to inhibit the activity of alpha-glucosidase enzyme; on the other hand S17 (11-(P-Bromoanilino)-5H-Dibenzo [B,E][1,4]Diazepine) and S5 (andrographolactone) have the potential to inhibit the activity of DPP-4 enzyme. These compounds have the potential to inhibit alpha- glucosidase and DPP-4 enzymes which act as antidiabetics.

References

Chao, W. W., & Lin, B. F. (2010). Isolation and identification of bioactive compounds in Andrographis paniculata (Chuanxinlian). Chinese Medicine, 5, 1–15. https://doi.org/10.1186/1749-8546-5-17

Cosconati, S., Forli, S., Perryman, A. L., Harris, R., Goodsell, D. S., & Olson, A. J. (2010). Cosconati2010.Pdf. 597–607.

Dai, Y., Chen, S. R., Chai, L., Zhao, J., Wang, Y., & Wang, Y. (2019). Overview of pharmacological activities of andrographis paniculata and its major compound andrographolide. Critical Reviews in Food Science and Nutrition, 59(0), S17–S29. https://doi.org/10.1080/10408398.2018.1501657

DiPiro, Joseph T., Gary C. Yee, L. Posey Michael, Stuart T. Haines, Thomas D. Nolin, and Ellingrod Vicky. 2020. Pharmacotherapy A Pathophysiologic Approach.

Dwivedi, M. K., Mishra, S., Sonter, S., & Singh, P. K. (2021). Diterpenoids as potential anti-malarial compounds from Andrographis paniculata. Beni-Suef University Journal of Basic and Applied Sciences, 10(1). https://doi.org/10.1186/s43088-021-00098-8

Jarukamjorn, K., & Nemoto, N. (2008). Pharmacological aspects of Andrographis paniculata on health and its major diterpenoid constituent andrographolide. Journal of Health Science, 54(4), 370–381. https://doi.org/10.1248/jhs.54.370

Julaiha, Widodo, G. P., & Herowati, R. (2019). Predicting ADME and molecular docking analysis of Andrographis paniculata and Strobilanthes crispus chemical constituents againts antidiabetic molecular targets. Journal of the Indonesian Chemical Society, 2(2), 106. https://doi.org/10.34311/jics.2019.02.2.106

Kalyaanamoorthy, S., & Chen, Y. P. (2011). Structure-based drug design to augment hit discovery. Drug Discovery Today, 16(17–18), 831–839. https://doi.org/10.1016/j.drudis.2011.07.006

Kementrian Kesehatan Republik Indonesia. 2020. Tetap produktif, cegah dan atasi Diabetes Mellitus. Pusat Data Dan Informasi Kementrian Kesehatan RI.

Knoll, E. H., Rao, Æ. S. N., Shaw, Æ. D. E., & Friesner, R. A. (2006). PHASE : a new engine for pharmacophore perception , 3D QSAR model development , and 3D database screening : 1 . Methodology and preliminary results. 647–671. https://doi.org/10.1007/s10822-006-9087-6

Kowalchick, J. E., Leiting, B., Pryor, K. A. D., Marsilio, F., Wu, J. K., He, H., Lyons, K. A., Eiermann, G. J., Petrov, A., Scapin, G., Patel, R. A., Thornberry, N. A., Weber, A. E., & Kim, D. (2007). Design, synthesis, and biological evaluation of triazolopiperazine-based β-amino amides as potent, orally active dipeptidyl peptidase IV (DPP-4) inhibitors. Bioorganic and Medicinal Chemistry Letters, 17(21), 5934–5939. https://doi.org/10.1016/j.bmcl.2007.07.100

Lipinski, C. A. (2004). Lead- and drug-like compounds: The rule-of-five revolution. Drug Discovery Today: Technologies, 1(4), 337–341. https://doi.org/10.1016/j.ddtec.2004.11.007

López-Camacho, E., García-Godoy, M. J., García-Nieto, J., Nebro, A. J., & Aldana-Montes, J. F. (2016). A new multi-objective approach for molecular docking based on rmsd and binding energy. Lecture Notes in Computer Science (Including Subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics), 9702, 65–77. https://doi.org/10.1007/978-3-319-38827-4_6

Meng, X., Zhang, H., Mezei, M., & Cui, M. (2011). Molecular docking : a powerful approach for structure-based drug discovery. 146–157.

Morris, G. M., Huey, R., & Olson, A. J. (2008). Using AutoDock for ligand-receptor docking (Issue December). https://doi.org/10.1002/0471250953.bi0814s24

Mushtaq, M. Y., Choi, Y. H., Verpoorte, R., & Wilson, E. G. (2014). Extraction for metabolomics: access to the metabolome. Phytochemical Analysis, 25(4), 291–306. https://doi.org/10.1002/pca.2505

Nugroho, A. E., Andrie, M., Warditiani, N. K., Siswanto, E., Pramono, S., & Lukitaningsih, E. (2012). Antidiabetic and antihiperlipidemic effect of Andrographis paniculata (Burm. f.) Nees and andrographolide in high-fructose-fat-fed rats. Indian Journal of Pharmacology, 44(3), 377–381. https://doi.org/10.4103/0253-7613.96343

Perkeni. (2019). Pedoman pengelolaan dan pencegahaan DM Tipe 2 dewasa Indonesia. Perkumpulan Endokrinologi Indonesia, 113.

Riverson, M., & Rizarullah, R. (2020). Potensi antidiabetes benzyl beta d glucopyranoside dari daun Yacon sebagai inhibitor enzim DPP-4: metode in silico. Prosiding Seminar Nasional Biotik 2020, 299–305.

Rohloff, J. (2015). Analysis of phenolic and cyclic compounds in plants using derivatization techniques in combination with GC-MS-based metabolite profiling. Molecules, 20(2), 3431–3462. https://doi.org/10.3390/molecules20023431

Roig-Zamboni, V., Cobucci-Ponzano, B., Iacono, R., Ferrara, M. C., Germany, S., Bourne, Y., Parenti, G., Moracci, M., & Sulzenbacher, G. (2017). Structure of human lysosomal acid α-glucosidase-A guide for the treatment of Pompe disease. Nature Communications, 8(1). https://doi.org/10.1038/s41467-017-01263-3

Safitri, S., Yolanda, R., Brahmana, E. M., Studi, P., Biologi, P., & Pengaraian, U. P. (2015). Di kecamatan Rambah Samo Kabupaten Rokan Hulu. Ejournal, 13(November 2014), 1–4.

Sivakumar, V., & Rajeshkumar, S. (2016). Protective effect of Andrographis paniculata on hyperglycemic mediated oxidative damage in renal tissues of diabetic rats. The Journal of Phytopharmacology, 4(6), 287–294. https://doi.org/10.31254/phyto.2015.4603

Solomon Jeeva, J. J. (2014). Andrographis paniculata: a review of its traditional uses, Phytochemistry and Pharmacology. Medicinal & Aromatic Plants, 03(04). https://doi.org/10.4172/2167-0412.1000169

Zheng, X., & Polli, J. (2010). Identification of inhibitor concentrations to efficiently screen and measure inhibition Ki values against solute carrier transporters. European Journal of Pharmaceutical Sciences, 41(1), 43–52. https://doi.org/10.1016/j.ejps.2010.05.013

Downloads

Published

2024-11-30

Issue

Vol. 14 No. 3 (2024): Pharmaciana

Section

Biology Pharmacy

License

Copyright (c) 2024 Herni Kusriani, Purwaniati Purwaniati, Muhamad Ilham Bintang

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with Pharmaciana agree to the following terms:

  1. Authors retain copyright and grant the journal the right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY-SA 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal. 
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.